InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
2
T+90 hit rate
14%
T+90 mean return
-19.8%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Telling Fred, Director. Insider active across 1 company, notably Oragenics INC. Aggregated, 10 filings have been logged. Split: 5 buys · 2 sells. Total volume traded: €78k. History available since 29 June 2021. The latest transaction was disclosed on 6 December 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
3,597 shares@ US$0.360.6% of flowCommon StockSEC:0001493152-24-049278:0
3,500 shares@ US$3.56815.6% of flowCommon StockSEC:0001493152-23-043456:0
25,000 shares0Common StockSEC:0001493152-23-027582:0
10,084 shares@ US$0.2860.10% mcap1.4% of flowCommon StockSEC:0001493152-22-017293:0
Ideal exit: 14 Mar 2023 (T+270)
3,500 shares@ US$0.28690.035% mcap0.5% of flowCommon StockSEC:0001493152-22-015040:0
Ideal exit: 17 Feb 2023 (T+270)
65,718 shares@ US$0.28360.66% mcap9.2% of flowCommon StockSEC:0001493152-22-014790:0
Ideal exit: 14 Feb 2023 (T+270)
15,303 shares@ US$0.2610.14% mcap2.0% of flowCommon StockSEC:0001493152-22-014605:0
Ideal exit: 12 Feb 2023 (T+270)
124,785 shares@ US$0.36291.53% mcap21.1% of flowCommon StockSEC:0001493152-22-008799:0
Ideal exit: 25 Dec 2022 (T+270)
156,540 shares@ US$0.4830.9% of flowCommon StockSEC:0001493152-21-015714
156,540 shares@ US$0.482.38% mcap32.9% of flowCommon StockSEC:0001493152-21-015714:0
10 of 10 declarations
About Telling Fred
Telling Fred is a Board Member at Oragenics Inc. In this role, he participates in the governance of the company and the development of its strategy. His experience in the biopharmaceutical sector allows him to make significant contributions to board discussions. He is committed to supporting Oragenics' growth objectives.
